Year |
Citation |
Score |
2020 |
Ayoub E, Zhang Y, Andreeff M, Perkins AS. MDS1-EVI1 Complex (MECOM) Activation Promotes Leukemic Stem Cell Quiescence By Upregulating CDKN1C/P57Kip2 Blood. 136: 6-7. DOI: 10.1182/blood-2020-143313 |
0.321 |
|
2018 |
Ayoub E, Wilson MP, McGrath KE, Li AJ, Frisch BJ, Palis J, Calvi LM, Zhang Y, Perkins AS. EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription. Nature Communications. 9: 4239. PMID 30315161 DOI: 10.1038/S41467-018-06208-Y |
0.376 |
|
2017 |
Fenouille N, Bassil CF, Ben-Sahra I, Benajiba L, Alexe G, Ramos A, Pikman Y, Conway AS, Burgess MR, Li Q, Luciano F, Auberger P, Galinsky I, DeAngelo DJ, Stone RM, ... ... Perkins AS, et al. The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia. Nature Medicine. PMID 28191887 DOI: 10.1038/Nm.4283 |
0.315 |
|
2016 |
Wilson M, Tsakraklides V, Tran M, Xiao YY, Zhang Y, Perkins AS. EVI1 interferes with myeloid maturation via transcriptional repression of Cebpa, via binding to two far downstream regulatory elements. The Journal of Biological Chemistry. PMID 27129260 DOI: 10.1074/Jbc.M115.708156 |
0.446 |
|
2016 |
Puissant A, Fenouille N, Bassil CF, Ben-Sahra I, Benajiba L, Alexe G, Ramos A, Pikman Y, Burgess MR, Li Q, Luciano F, Auberger P, Galinsky I, DeAngelo DJ, Stone RM, ... Perkins AS, et al. Targeting the Creatine Kinase Pathway in EVI1-Positive Acute Myeloid Leukemia Blood. 128: 523-523. DOI: 10.1182/Blood.V128.22.523.523 |
0.373 |
|
2014 |
Bard-Chapeau EA, Szumska D, Jacob B, Chua BQ, Chatterjee GC, Zhang Y, Ward JM, Urun F, Kinameri E, Vincent SD, Ahmed S, Bhattacharya S, Osato M, Perkins AS, Moore AW, et al. Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defects. Plos One. 9: e89397. PMID 24586749 DOI: 10.1371/Journal.Pone.0089397 |
0.333 |
|
2014 |
Glass C, Wilson M, Gonzalez R, Zhang Y, Perkins AS. The role of EVI1 in myeloid malignancies. Blood Cells, Molecules & Diseases. 53: 67-76. PMID 24495476 DOI: 10.1016/J.Bcmd.2014.01.002 |
0.575 |
|
2013 |
Zhang Y, Owens K, Hatem L, Glass CH, Karuppaiah K, Camargo F, Perkins AS. Essential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia. Blood. 122: 2888-92. PMID 24021671 DOI: 10.1182/Blood-2012-08-453662 |
0.545 |
|
2013 |
Glass C, Wuertzer C, Cui X, Bi Y, Davuluri R, Xiao YY, Wilson M, Owens K, Zhang Y, Perkins A. Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia. Plos One. 8: e67134. PMID 23826213 DOI: 10.1371/Journal.Pone.0067134 |
0.537 |
|
2013 |
Zhang Y, Cui X, Wuertzer CA, Perkins AS. EVI1, A Potential Regulator Of CEBPA; A Contributory Mechanism In Leukemogenesis? Blood. 122: 2495-2495. DOI: 10.1182/Blood.V122.21.2495.2495 |
0.38 |
|
2012 |
Bresnick EH, Katsumura KR, Lee HY, Johnson KD, Perkins AS. Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies. Nucleic Acids Research. 40: 5819-31. PMID 22492510 DOI: 10.1093/Nar/Gks281 |
0.393 |
|
2011 |
Zhang Y, Sicot G, Cui X, Vogel M, Wuertzer CA, Lezon-Geyda K, Wheeler J, Harki DA, Muzikar KA, Stolper DA, Dervan PB, Perkins AS. Targeting a DNA binding motif of the EVI1 protein by a pyrrole-imidazole polyamide. Biochemistry. 50: 10431-41. PMID 22039883 DOI: 10.1021/Bi200962U |
0.367 |
|
2011 |
Zhang Y, Stehling-Sun S, Lezon-Geyda K, Juneja SC, Coillard L, Chatterjee G, Wuertzer CA, Camargo F, Perkins AS. PR-domain-containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function. Blood. 118: 3853-61. PMID 21666053 DOI: 10.1182/Blood-2011-02-334680 |
0.331 |
|
2010 |
Halene S, Gaines P, Sun H, Zibello T, Lin S, Khanna-Gupta A, Williams SC, Perkins A, Krause D, Berliner N. C/EBPepsilon directs granulocytic-vs-monocytic lineage determination and confers chemotactic function via Hlx. Experimental Hematology. 38: 90-103. PMID 19925846 DOI: 10.1016/J.Exphem.2009.11.004 |
0.337 |
|
2008 |
Qiu Y, Lynch J, Guo L, Yatsula B, Perkins AS, Michalak M. Regulation of the calreticulin gene by GATA6 and Evi-1 transcription factors. Biochemistry. 47: 3697-704. PMID 18303859 DOI: 10.1021/Bi702524V |
0.373 |
|
2008 |
Perkins AS, Campo JJd, Xiao Y, Zhang Y, Lin SJ, Dudley J, Tuck D, Yatsula B. EVI1 Blocks Apoptosis in DA-1 Myeloid Leukemia Cells Via Enhanced Transcription of the Prosurvival Gene Bcl2a1 (A1) Blood. 112: 3805-3805. DOI: 10.1182/Blood.V112.11.3805.3805 |
0.333 |
|
2008 |
Sicot G, Vogel M, Zhang Y, Harki DA, Lezon-Geyda K, Dervan P, Perkins AS. Development of a Novel Polyamide-Based Agent to Inhibit EVI1 Function Blood. 112: 2660-2660. DOI: 10.1182/Blood.V112.11.2660.2660 |
0.411 |
|
2006 |
Boyd KE, Xiao YY, Fan K, Poholek A, Copeland NG, Jenkins NA, Perkins AS. Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR. Blood. 107: 733-41. PMID 16204320 DOI: 10.1182/Blood-2003-05-1626 |
0.364 |
|
2006 |
Perkins AS, Lin S, delCampo J, Camargo F, Lezon-Geyda K. Analysis of a LacZ Knock-In Allele of MDS1 Indicates a Critical Role in Hematopoietic Development. Blood. 108: 444-444. DOI: 10.1182/Blood.V108.11.444.444 |
0.318 |
|
2005 |
Yatsula B, Lin S, Read AJ, Poholek A, Yates K, Yue D, Hui P, Perkins AS. Identification of binding sites of EVI1 in mammalian cells. The Journal of Biological Chemistry. 280: 30712-22. PMID 16006653 DOI: 10.1074/Jbc.M504293200 |
0.43 |
|
2005 |
Yuasa H, Oike Y, Iwama A, Nishikata I, Sugiyama D, Perkins A, Mucenski ML, Suda T, Morishita K. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression. The Embo Journal. 24: 1976-87. PMID 15889140 DOI: 10.1038/Sj.Emboj.7600679 |
0.458 |
|
2005 |
Perkins AS, Xiao Y, Lezon-Geyda K, Lin S, Camargo F, Tuck D, Yatsula B. Role of EVI1 in Cell Cycle Regulation: Relevance of Specific Target Genes. Blood. 106: 1614-1614. DOI: 10.1182/BLOOD.V106.11.1614.1614 |
0.499 |
|
2002 |
Ma X, Husain T, Peng H, Lin S, Mironenko O, Maun N, Johnson S, Tuck D, Berliner N, Krause DS, Perkins AS. Development of a murine hematopoietic progenitor complementary DNA microarray using a subtracted complementary DNA library. Blood. 100: 833-44. PMID 12130493 DOI: 10.1182/Blood.V100.3.833 |
0.348 |
|
1998 |
Nottoli T, Hagopian-Donaldson S, Zhang J, Perkins A, Williams T. AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice Proceedings of the National Academy of Sciences of the United States of America. 95: 13714-13719. PMID 9811866 DOI: 10.1073/Pnas.95.23.13714 |
0.307 |
|
1998 |
Kim JH, Hui P, Yue D, Aycock J, Leclerc C, Bjoring AR, Perkins AS. Identification of candidate target genes for EVI-1, a zinc finger oncoprotein, using a novel selection strategy. Oncogene. 17: 1527-38. PMID 9794230 DOI: 10.1038/sj.onc.1202331 |
0.345 |
|
1996 |
Lopingco MC, Perkins AS. Molecular analysis of Evi1, a zinc finger oncogene involved in myeloid leukemia. Current Topics in Microbiology and Immunology. 211: 211-22. PMID 8585952 DOI: 10.1007/978-3-642-85232-9_21 |
0.498 |
|
1992 |
Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes & Development. 6: 2235-47. PMID 1459449 |
0.307 |
|
1991 |
Perkins AS, Fishel R, Jenkins NA, Copeland NG. Evi-1, a Murine Zinc Finger Proto-Oncogene, Encodes a Sequence-Specific DNA-Binding Protein Molecular and Cellular Biology. 11: 2665-2674. PMID 2017172 DOI: 10.1128/Mcb.11.5.2665 |
0.311 |
|
Show low-probability matches. |